Sedana Medical AB (publ)
STO:SEDANA
Sedana Medical AB (publ)
Gross Profit
Sedana Medical AB (publ)
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Gross Profit
kr126.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Gross Profit
kr6.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Gross Profit
kr597.9m
|
CAGR 3-Years
31%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Gross Profit
kr487.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
|
|
Getinge AB
STO:GETI B
|
Gross Profit
kr16.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Gross Profit
kr4.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
Glance View
Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
See Also
What is Sedana Medical AB (publ)'s Gross Profit?
Gross Profit
126.1m
SEK
Based on the financial report for Dec 31, 2024, Sedana Medical AB (publ)'s Gross Profit amounts to 126.1m SEK.
What is Sedana Medical AB (publ)'s Gross Profit growth rate?
Gross Profit CAGR 5Y
38%
Over the last year, the Gross Profit growth was 16%. The average annual Gross Profit growth rates for Sedana Medical AB (publ) have been 6% over the past three years , 38% over the past five years .
You don't have any saved screeners yet